Faeth Therapeutics (FTH) vs Olema Pharmaceuticals (OLMA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Faeth Therapeutics (FTH) has outperformed Olema Pharmaceuticals (OLMA) over the past year, gaining 121.4% versus a loss of 23.9%. Over five years, OLMA leads with a -74.1% price change compared with -83.7% for FTH. Olema Pharmaceuticals is the larger company by market cap ($694.7 million vs $643.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | FTH | OLMA |
|---|---|---|
| Share price | $24.92 | $7.94 |
| Market cap | $643.94M | $694.73M |
| 1-day change | -7.33% | +0.25% |
| YTD return | +133.55% | -68.24% |
| 1-year return | +121.39% | -23.95% |
| 5-year return | -83.67% | -74.15% |
| EPS (TTM) | $-60.86 | $-2.12 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $42.14 | $36.26 |
| 52-week low | $7.45 | $6.65 |
| Distance from 52-week high | -40.87% | -78.10% |
| Average volume | 348.41K | 1.07M |
| Shares outstanding | 25.84M | 87.50M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- FTH has outperformed OLMA by 145.3 percentage points over the past year.
FTH vs OLMA FAQ
Which is bigger, Faeth Therapeutics or Olema Pharmaceuticals?
Olema Pharmaceuticals (OLMA) is larger, with a market capitalization of $694.73M compared with $643.94M for Faeth Therapeutics (FTH).
Which stock has performed better over the past year, FTH or OLMA?
FTH returned +121.39% over the past 12 months, compared with -23.95% for OLMA (price return, excluding dividends). Past performance does not predict future results.
Are Faeth Therapeutics and Olema Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.